DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 02 · Volume 23 · 2003 DOI: 10.1055/s-002-2637 HIV, AIDS, and the Liver Editor in Chief Paul D. Berk M.D., Guest Editor Douglas T. Dieterich M.D.

  • C-1

    Continuing Medical Education

  • 107
    Dieterich, Douglas T.:

    Human Immunodeficiency Virus and the Liver: Lessons Learned and Still to Be Learned

  • 115
    Burger, Susanne; Poles, Michael A.:

    Natural History and Pathogenesis of Human Immunodeficiency Virus Infection

  • 125
    Thio, Chloe L.:

    Hepatitis B in the Human Immunodeficiency Virus-Infected Patient: Epidemiology, Natural History, and Treatment

  • 137
    Stapleton, Jack T.:

    GB Virus Type C/Hepatitis G Virus

  • 149
    Gonzalez, Stevan A.; Talal, Andrew H.:

    Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals: An Emerging Comorbidity with Significant Implications

  • 167
    Montessori, Valentina; Harris, Marianne; Montaner, Julio S. G.:

    Hepatotoxicity of Nucleoside Reverse Transcriptase Inhibitors

  • 173
    Kontorinis, Nickolas; Dieterich, Douglas T.:

    Toxicity of Non-Nucleoside Analogue Reverse Transcriptase Inhibitors

  • 183
    Sulkowski, Mark S.:

    Hepatotoxicity Associated with Antiretroviral Therapy Containing HIV-1 Protease Inhibitors

  • 195
    Yerian, Lisa M.; Brady, Lynda; Hart, John:

    Hepatic Manifestations of Jeune Syndrome (Asphyxiating Thoracic Dystrophy)